FDA “Safety First” Initiative, Agency’s Requests Draw Doubts From DeLauro
This article was originally published in The Tan Sheet
Executive Summary
FDA is implementing the Safety First initiative to "ensure that significant post-market safety issues are our highest priority," according to acting Center for Drug Evaluation and Research Director Janet Woodcock
You may also be interested in...
FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports
FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.
FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports
FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.
Elections Reshape FDA Oversight Scene On Capitol Hill
The Republican takeover in the House shuffles the leadership in committees crucial to the dietary supplement and OTC drug industries while likely setting the stage for cuts to FDA funding.